VPS9D1 and prostate carcinoma: For examples, VPS9D1-AS1 (also called MYU) boosts prostate cancer cell proliferation by mediation of miR-184c-Myc axis [21]; increased expression of VPS9D1-AS1 predicts dismal prognosis in non-small cell lung cancer [22].